» Authors » Sylvia Veen

Sylvia Veen

Explore the profile of Sylvia Veen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 307
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ter Wolbeek M, Kavelaars A, de Vries W, Tersteeg-Kamperman M, Veen S, Kornelisse R, et al.
Brain Behav Immun . 2014 Dec; 45:128-38. PMID: 25449580
Neonatal glucocorticoid (GC) treatment is used to prevent bronchopulmonary dysplasia (BPD) in prematurely born babies. In the 1990s, treatment regimens with relatively high doses of dexamethasone (DEX) were common. As...
2.
Ter Wolbeek M, de Sonneville L, de Vries W, Kavelaars A, Veen S, Kornelisse R, et al.
Psychoneuroendocrinology . 2012 Oct; 38(7):975-86. PMID: 23107421
Objective: To reduce the risk of bronchopulmonary dysplasia, preterm infants receive neonatal treatment with glucocorticoids, mostly dexamethasone (DEX). Compared to current protocols, treatment regimens of the late 1980s - early...
3.
Kaandorp J, van Bel F, Veen S, Derks J, Groenendaal F, Rijken M, et al.
Arch Dis Child Fetal Neonatal Ed . 2011 Nov; 97(3):F162-6. PMID: 22102633
Objective: Free-radical-induced reperfusion injury has been recognised as an important cause of brain tissue damage after birth asphyxia. Allopurinol reduces the formation of free radicals, thereby potentially limiting the amount...
4.
Maguire C, Walther F, Sprij A, le Cessie S, Wit J, Veen S
Pediatrics . 2009 Sep; 124(4):1021-30. PMID: 19786441
Objective: The goal was to investigate the effects of the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) on days of respiratory support and intensive care, growth, and neuromotor development...
5.
Maguire C, Walther F, van Zwieten P, le Cessie S, Wit J, Veen S
Pediatrics . 2009 Apr; 123(4):1081-7. PMID: 19336365
Objective: This was a randomized, controlled trial to investigate the effect of Newborn Individualized Developmental Care and Assessment Program on growth, cognitive, psychomotor, and neuromotor development at 1 and 2...
6.
Karemaker R, Karemaker J, Kavelaars A, Tersteeg-Kamperman M, Baerts W, Veen S, et al.
Pediatrics . 2008 Nov; 122(5):978-87. PMID: 18977976
Objective: The goal was to investigate cardiovascular responses to a psychosocial stressor in school-aged, formerly premature boys and girls who had been treated neonatally with dexamethasone or hydrocortisone because of...
7.
de Vries W, Karemaker R, Mooy N, Strengers J, Kemperman H, Baerts W, et al.
Arch Pediatr Adolesc Med . 2008 Aug; 162(8):738-44. PMID: 18678806
Objective: To study whether antenatal or neonatal glucocorticoid therapy to reduce the incidence and severity of chronic lung disease in preterm infants is associated with long-term adverse cardiac effects and...
8.
Leijser L, Liauw L, Veen S, de Boer I, Walther F, van Wezel-Meijler G
Neuroradiology . 2008 Jun; 50(9):799-811. PMID: 18545992
Introduction: Periventricular white matter (WM) echodensities, frequently seen in preterm infants, can be associated with suboptimal neurodevelopment. Major WM injury is well detected on cranial ultrasound (cUS). cUS seems less...
9.
Karemaker R, Kavelaars A, Ter Wolbeek M, Tersteeg-Kamperman M, Baerts W, Veen S, et al.
Pediatrics . 2008 Apr; 121(4):e870-8. PMID: 18381516
Objective: To compare long-term effects of neonatal treatment with dexamethasone or hydrocortisone for chronic lung disease of prematurity on the hypothalamus-pituitary-adrenal axis and the immune response in children at school...
10.
Maguire C, Veen S, Sprij A, le Cessie S, Wit J, Walther F
Pediatrics . 2008 Feb; 121(2):e239-45. PMID: 18245399
Objective: The goal of this study was to investigate the effect of basic elements of developmental care (incubator covers and positioning aids) on days of respiratory support and intensive care,...